Living Donors Clinical Trial
Official title:
Renal and Lung Living Donors Evaluation (RELIVE) Informed Consent Study
Verified date | March 2017 |
Source | National Institute of Allergy and Infectious Diseases (NIAID) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
An organ transplant is frequently the best option and, in some cases, the only option to save the lives of transplant recipients. Receiving an organ from a living donor eliminates the need to wait for a deceased donor, an option that many transplant recipients do not survive. However, donating an organ presents health concerns to the donor as well. This study will use surveys to evaluate the understanding of risk and psychological pressure that living organ donors felt when making the decision to donate. It will also compare participants' answers across geographic, racial and socio-economic backgrounds.
Status | Completed |
Enrollment | 624 |
Est. completion date | November 2010 |
Est. primary completion date | November 2010 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Living donor of a kidney or lung Exclusion Criteria: - Unable to give informed consent |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
National Institute of Allergy and Infectious Diseases (NIAID) |
Valapour M, Kahn JP, Bailey RF, Matas AJ. Assessing elements of informed consent among living donors. Clin Transplant. 2011 Mar-Apr;25(2):185-90. doi: 10.1111/j.1399-0012.2010.01374.x. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Questionnaire Score 1 | Feelings of pressure to donate an organ on a 4-point scale e.g.; "1: No pressure" to "4: A lot of pressure." | Change from 1 week prior to donation and 3 months after donation | |
Primary | Questionnaire Score 2 | Understanding of the donor screening process on a 4-point scale e.g.; "1: No understanding" to "4: Full understanding." | Change from 1 week prior to donation and 3 months after donation | |
Primary | Questionnaire Score 3 | Understanding of medical and psychosocial consequences of organ donation on a 4-point scale e.g.; "1: No understanding" to "4: Full understanding." | Change from 1 week prior to donation and 3 months after donation | |
Secondary | Questionnaire Score Secondary Endpoint 1 | Understanding of short-term medical risks of donation answered on a 4-point scale e.g.; "1: No understanding" to "4: Full understanding." | Change from 1 week prior to donation and 3 months after donation | |
Secondary | Questionnaire Score Secondary Endpoint 2 | Understanding of long-term medical risks of donation expressed by donors on a scale of 1 to 4 e.g.; "1: No understanding" to "4: Full understanding." | Change from 1 week prior to donation and 3 months after donation | |
Secondary | Questionnaire Score Secondary Endpoint 3 | Understanding of psychological risks of donation expressed by donors on a scale of 1 to 4 e.g.; "1: No understanding" to "4: Full understanding." | Change from 1 week prior to donation and 3 months after donation | |
Secondary | Questionnaire Score Secondary Endpoint 4 | Understanding that recipients may have variable outcomes as expressed by donors on a scale of 1 to 4 e.g.; "1: No understanding" to "4: Full understanding." | Change from 1 week prior to donation and 3 months after donation |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT01150487 -
Paired Marrow Aspirations to Assess Assays in Sensitized Renal Allograft Recipients
|
N/A | |
Completed |
NCT01236326 -
Conventional Laparoscopic Versus Laparoendoscopic Single Site Donor Nephrectomy in Living Donor Kidney Transplantation
|
N/A | |
Completed |
NCT01046955 -
Thymoglobulin Versus Alemtuzumab Versus Daclizumab in Living Donor Renal Transplantation
|
Phase 4 | |
Active, not recruiting |
NCT03400085 -
Pilot Study of an mHealth Intervention for Living Donor Follow-up
|
N/A | |
Active, not recruiting |
NCT03090646 -
Use of Financial Incentives to Increase Live Kidney Donor Follow-up Compliance
|
N/A | |
Completed |
NCT00258986 -
Efficacy Study Comparing Hand-assisted Laparoscopic and Mini-incision Muscle Splitting Incision Living Donor Nephrectomy
|
Phase 3 | |
Completed |
NCT01009229 -
A Reduced 11-b-HSD Activity, a Novel Mechanism of Salt Sensitivity and Hypertension After Renal Allograft Donation?
|
N/A | |
Completed |
NCT00777933 -
Randomized Trial of Cyclosporine and Tacrolimus Therapy With Steroid Withdrawal in Living-Donor Renal Transplantation
|
N/A | |
Completed |
NCT01136395 -
Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation
|
Phase 2 | |
Completed |
NCT01059331 -
Postoperative Analgesia After Laparoscopic Living Donor Nephrectomy
|
Phase 4 | |
Not yet recruiting |
NCT06210555 -
Multiparametric MRI in a Prospective Cohort of Living Kidney Donors, Recipients, and Healthy Controls: Correlations With Markers of Renal Function, Fibrosis and Ageing
|